Hammerhead Ribozyme-Mediated Sensitization of Human Tumor Cells after Treatment with 1,3-Bis(2-chloroethyl)-1-nitrosourea

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 2, 2004, Pages 506-514

  Zhang, Qiwei ^a   Ohannesian, David W ^a   Erickson, Leonard C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 (4 IODOPHENYL) 2 (4 NITROPHENYL) 2H 5 TETRAZOLIO] 1,3 BENZENEDISULFONATE; 6 O BENZYLGUANINE; BENZENESULFONIC ACID DERIVATIVE; CARMUSTINE; HAMMERHEAD RIBOZYME; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; RIBOZYME; UNCLASSIFIED DRUG; WST 1;

ARTICLE; CELL KILLING; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIZATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE THERAPY; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; POINT MUTATION; PRIORITY JOURNAL; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS, ALKYLATING; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARMUSTINE; CELL DIVISION; CELL EXTRACTS; HELA CELLS; HUMANS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RNA; RNA, CATALYTIC; STEM CELLS; TETRAZOLIUM SALTS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 2142697183     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.061507     Document Type: Article

References (34)

1. Aigner A, Fischer D, Merdan T, Brus C, Kissel T, and Czubayko F (2002) Delivery of unmodified bioactive ribozymes by an RNA-stablizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression. Gene Ther 9:1700-1707.
2. Birikh KR, Heaton PA, and Eckstein F (1997) The structure, function and application of the hammerhead ribozyme. Eur J Biochem 245:1-16.
3. Bratty J, Chartrand P, Ferbeyre G, and Cedergren R (1993) The hammerhead RNA domain, a model ribozyme. Biochim Biophys Acta 1216:345-359.
4. Carter SK and Wasserman TH (1976) The nitrosoureas-thoughts for the future. Cancer Treat Rep. 60:807-811.
5. Cech TR (1987) The chemistry of self-splicing RNA and RNA enzymes. Science (Wash DC) 236:1532-1539.
6. Citti L, Eckstein F, Capecchi B, Mariani L, Nevischi S, Poggi A, and Rainaldi G (1999) Transient transfection of a synthetic hammerhead ribozyme targeted against human MGMT gene to cells in culture potentiates the genotoxicity of the alkylation damage induced by mitozolomide. Antisense Nucleic Acid Drug Dev 9:125-133.
7. 6-methylguanine-DNA methyltransferase molecules escaped from inactivation. Mutat Res 409:173-179.
8. Curcio LD, Bouffard DY, and Scanlon KJ (1997) Oligonucleotides as modulators of cancer gene expression. Pharmacol Ther 74:317-332.
9. Dahm SC and Uhlenbeck OC (1991) Role of divalent metal ions in the hammerhead RNA cleavage reaction. Biochemistry 30:9464-9469.
10. 6-methylguanine. Cancer Chemother Pharmacol 25:103-108.
11. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res 51:3367-3672.
12. Domi A, Beaud G, and Favre A (1996) Transcripts containing a small anti-HIV hammerhead ribozyme that are active in the cell cytoplasm but inactive in vitro as free RNAs. Biochimie 78:654-662.
13. Erickson LC (1991) The role of O-6 methylguanine DNA methyltransferase (MGMT) in drug resistance and strategies for its inhibition. Semin Cancer Biol 2:257-265.
14. Futscher BW, Misctich KC, Bare DM, Fisher RI, and Erickson LC (1989) Inhibition of a specific DNA repair system and nitrosourea cytotoxicity in resistant human cancer cells. Cancer Commun 1:65-73.
15. Grassi G and Marini JC (1996) Ribozymes: structure, function and potential therapy for dominant genetic disorders. Ann Med 28:499-510.
16. Haseloff J and Gerlach WL (1988) Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature (Lond) 334:585-591.
17. Heindenreich O, Kang S-H, Brown DA, Xu X, Swiderski P, Rossi JJ, Eckstein F, and Nerenberg M (1995) Ribozyme-mediated RNA degradation in nuclei suspension. Nucleic Acids Res 23:2223-2228.
18. Herschlag D, Khosla M, Tsuchihashi Z, and Karpel RL (1994) An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis. EMBO (Eur Mol Biol Organ) J 13:2913-2924.
19. Kokkinakis DM, Bocangel DB, Schold SC, Moschel RC, and Pegg AE (2001) Thresholds of O6-alkylguanine DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide. Clin Cancer Res 7:421-428.
20. Kreklau EL, Kurpad C, Williams DA, and Erickson LC (1999) Prolonged inhibition of O(6)-methylguanine DNA methyltransferase in human tumor cells by O(6)-benzylguanine in vitro and in vivo. J Pharmacol Exp Ther 291:1269-1275.
21. 6-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase. Nucl Acids Res 29:2558-2566.
22. + human tumor cells. Carcinogenesis 16:2255-2257.
23. L'Huillier PJ, Davis SR, and Bellamy AR (1992) Cytoplasmic delivery of ribozymes leads to efficient reduction in alpha-lactalbumin mRNA levels in C1271 mouse cells. EMBO(Eur Mol Biol Organ) J 11:4411-4418.
24. Lieber A and Strauss M (1995) Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol Cell Biol 15:540-551.
25. Mitra S and Kaina B (1993) Regulation ofrepair of alkylation damage in mammalian genomes. Prog Nucleic Acid Res Mol Biol 44:109-142.
26. 6-methylguanine-DNA methyltransferase expression. Cancer Res 53:1731-1734.
27. Ruffner DE, Stormo GD, and Uhlenbeck OC (1990) Sequence requirements of the hammerhead RNA self-cleavage reaction. Biochemistry 29:10695-10702.
28. Scanlon KJ, Ohta Y, Ishida H, Kijima H, Ohkawa T, Kaminski A, Tsai J, Horng G, and Kashani-Sabet M (1995) Oligonucleotide-mediated modulation of mammalian gene expression. FASEB J 9:1288-1296.
29. Shi N and Pardridge WM (2000) Noninvasive gene targeting to the brain. Proc Natl Acad Sci USA 97:7567-7572.
30. Sun LQ, Warrilow D, Wang L, Witherington C, Macpherson J, and Symonds G (1994) Ribozyme-mediated suppression of Moloney murine leukemia virus and human-immunodeficiency-virus type I replication in permissive cell lines. Proc Natl Acad Sci USA 91:9715-9719.
31. 6-alkylguanine. Proc Natl Acad Sci USA 87:686-690.
32. Tsuchihashi Z, Khosla M, and Herschlag D (1993) Protein enhancement of hammerhead ribozyme catalysis. Science (Wash DC) 262:99-102.
33. Woisard A, Jean-Louis Fourrey, Alain Favre (1994) Multiple folded conformations of a hammerhead ribozyme domain under cleavage conditions. J Mol Biol 239:366-370.
34. Zhang Q, Ohannesian DW, Kreklau EL, and Erickson LC (2001) Modulation of 1,3-bis-(2-chloroethyl)-1-nitrosourea resistance in human tumor cells using hammerhead ribozymes designed to degrade O6-methylguanine DNA methyltransferase mRNA. J Pharmacol Exp Ther 298:141-147.